Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results